Cargando…
Antidepressant Effects of a Persian Medicine Remedy on Multiple Sclerosis Patients: A Double-Blinded Randomized Clinical Trial
BACKGROUND: Multiple sclerosis (MS), an inflammatory neurodegenerative disease of the central nervous system, is accompanied by some psychiatric disorders, one prominent example of which is depression. The aim of this study was to investigate the effects of a Persian herbal medicine treatment that c...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Salvia Medical Sciences Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343653/ https://www.ncbi.nlm.nih.gov/pubmed/34466472 http://dx.doi.org/10.31661/gmj.v8i0.1212 |
_version_ | 1783734327572430848 |
---|---|
author | Adalat, Maryam Khalili, Mohammad Ayromlou, Hormoz Haririan, Sajjad Fazljou, Seyyed Mohammad Bagher Rezaeizadeh, Hossein Safari, Ali Akbar Zargaran, Arman |
author_facet | Adalat, Maryam Khalili, Mohammad Ayromlou, Hormoz Haririan, Sajjad Fazljou, Seyyed Mohammad Bagher Rezaeizadeh, Hossein Safari, Ali Akbar Zargaran, Arman |
author_sort | Adalat, Maryam |
collection | PubMed |
description | BACKGROUND: Multiple sclerosis (MS), an inflammatory neurodegenerative disease of the central nervous system, is accompanied by some psychiatric disorders, one prominent example of which is depression. The aim of this study was to investigate the effects of a Persian herbal medicine treatment that contains Crocus sativus, Hypericum perforatum, Cinnamon verum, and Vitis vinifera on fatigue and sleep disorders in MS patients. MATERIALS AND METHODS: A Persian medicine remedy containing C.sativus, H.perforatum, C.verum, and V.vinifera was tested for its ability to improve the symptoms of depression in MS patients. This randomized double-blind clinical study was performed among 52 patients with MS who were allocated to their respective research groups through blocked randomization. The patients were treated for 4 weeks with either the drug or the placebo. To quantify the symptoms of depression, Beck depression inventory (BDI) was used. RESULTS: Forty-six patients completed the study. In the course of the study, as the primary outcome, BDI decreased in the drug group (p =0.000) and the placebo group (p =0.001) significantly, but the rate of change in the drug group was significantly higher than in the placebo group (-13.9 ± 8.6 vs. -3.9 ± 4.3, p =0.000). While analyzing time and treatment effect for BDI, significant decreases in BDI were observed for the drug group, but not in the placebo group (p = 0.001). CONCLUSION: The present study suggests that Persian medicine remedy treatment in combination with chemical drugs may improve depression symptoms in MS patients. More investigations are needed to discover the exact mechanisms and processes involved. |
format | Online Article Text |
id | pubmed-8343653 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Salvia Medical Sciences Ltd
|
record_format | MEDLINE/PubMed |
spelling | pubmed-83436532021-08-30 Antidepressant Effects of a Persian Medicine Remedy on Multiple Sclerosis Patients: A Double-Blinded Randomized Clinical Trial Adalat, Maryam Khalili, Mohammad Ayromlou, Hormoz Haririan, Sajjad Fazljou, Seyyed Mohammad Bagher Rezaeizadeh, Hossein Safari, Ali Akbar Zargaran, Arman Galen Med J Original Article BACKGROUND: Multiple sclerosis (MS), an inflammatory neurodegenerative disease of the central nervous system, is accompanied by some psychiatric disorders, one prominent example of which is depression. The aim of this study was to investigate the effects of a Persian herbal medicine treatment that contains Crocus sativus, Hypericum perforatum, Cinnamon verum, and Vitis vinifera on fatigue and sleep disorders in MS patients. MATERIALS AND METHODS: A Persian medicine remedy containing C.sativus, H.perforatum, C.verum, and V.vinifera was tested for its ability to improve the symptoms of depression in MS patients. This randomized double-blind clinical study was performed among 52 patients with MS who were allocated to their respective research groups through blocked randomization. The patients were treated for 4 weeks with either the drug or the placebo. To quantify the symptoms of depression, Beck depression inventory (BDI) was used. RESULTS: Forty-six patients completed the study. In the course of the study, as the primary outcome, BDI decreased in the drug group (p =0.000) and the placebo group (p =0.001) significantly, but the rate of change in the drug group was significantly higher than in the placebo group (-13.9 ± 8.6 vs. -3.9 ± 4.3, p =0.000). While analyzing time and treatment effect for BDI, significant decreases in BDI were observed for the drug group, but not in the placebo group (p = 0.001). CONCLUSION: The present study suggests that Persian medicine remedy treatment in combination with chemical drugs may improve depression symptoms in MS patients. More investigations are needed to discover the exact mechanisms and processes involved. Salvia Medical Sciences Ltd 2019-01-01 /pmc/articles/PMC8343653/ /pubmed/34466472 http://dx.doi.org/10.31661/gmj.v8i0.1212 Text en Copyright© 2019, Galen Medical Journal. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ) |
spellingShingle | Original Article Adalat, Maryam Khalili, Mohammad Ayromlou, Hormoz Haririan, Sajjad Fazljou, Seyyed Mohammad Bagher Rezaeizadeh, Hossein Safari, Ali Akbar Zargaran, Arman Antidepressant Effects of a Persian Medicine Remedy on Multiple Sclerosis Patients: A Double-Blinded Randomized Clinical Trial |
title | Antidepressant Effects of a Persian Medicine Remedy on Multiple Sclerosis Patients: A Double-Blinded Randomized Clinical Trial |
title_full | Antidepressant Effects of a Persian Medicine Remedy on Multiple Sclerosis Patients: A Double-Blinded Randomized Clinical Trial |
title_fullStr | Antidepressant Effects of a Persian Medicine Remedy on Multiple Sclerosis Patients: A Double-Blinded Randomized Clinical Trial |
title_full_unstemmed | Antidepressant Effects of a Persian Medicine Remedy on Multiple Sclerosis Patients: A Double-Blinded Randomized Clinical Trial |
title_short | Antidepressant Effects of a Persian Medicine Remedy on Multiple Sclerosis Patients: A Double-Blinded Randomized Clinical Trial |
title_sort | antidepressant effects of a persian medicine remedy on multiple sclerosis patients: a double-blinded randomized clinical trial |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343653/ https://www.ncbi.nlm.nih.gov/pubmed/34466472 http://dx.doi.org/10.31661/gmj.v8i0.1212 |
work_keys_str_mv | AT adalatmaryam antidepressanteffectsofapersianmedicineremedyonmultiplesclerosispatientsadoubleblindedrandomizedclinicaltrial AT khalilimohammad antidepressanteffectsofapersianmedicineremedyonmultiplesclerosispatientsadoubleblindedrandomizedclinicaltrial AT ayromlouhormoz antidepressanteffectsofapersianmedicineremedyonmultiplesclerosispatientsadoubleblindedrandomizedclinicaltrial AT haririansajjad antidepressanteffectsofapersianmedicineremedyonmultiplesclerosispatientsadoubleblindedrandomizedclinicaltrial AT fazljouseyyedmohammadbagher antidepressanteffectsofapersianmedicineremedyonmultiplesclerosispatientsadoubleblindedrandomizedclinicaltrial AT rezaeizadehhossein antidepressanteffectsofapersianmedicineremedyonmultiplesclerosispatientsadoubleblindedrandomizedclinicaltrial AT safarialiakbar antidepressanteffectsofapersianmedicineremedyonmultiplesclerosispatientsadoubleblindedrandomizedclinicaltrial AT zargaranarman antidepressanteffectsofapersianmedicineremedyonmultiplesclerosispatientsadoubleblindedrandomizedclinicaltrial |